ContentsSynopsisCodesLook ForDiagnostic PearlsDifferential Diagnosis & PitfallsBest TestsManagement PearlsTherapyReferences
Essential thrombocythemia
Print
Other Resources UpToDate PubMed

Essential thrombocythemia

Print Images (1)
Contributors: Nina Haghi MD, Carla Casulo MD, Paritosh Prasad MD
Other Resources UpToDate PubMed

Synopsis

Essential thrombocythemia (ET) is a chronic myeloproliferative disorder characterized by abnormal proliferation of megakaryocytes and platelets that originate from clonal proliferation in the bone marrow. Patients have significant and sustained elevated platelet counts (≥ 450 x 109/L).

Most cases occur in patients aged 50-60 years, although there is another peak incidence in female patients of approximately 30 years of age. ET accounts for approximately one-third of BCR-ABL-negative myeloproliferative neoplasms.

Almost half of all patients with ET present incidentally when thrombocytosis is noted on routine blood work. Others will present with complications (vascular occlusion / thrombosis, hemorrhage, bleeding, or first trimester pregnancy loss) or disease-related symptoms (headache, vision changes, dizziness, splenomegaly). Between 13% and 40% of patients will have "vasomotor" symptoms due to microvascular disturbance, which can include headache, syncope or presyncope, chest pain, transient visual disturbances, acral paresthesias, and skin findings such as livedo reticularis or erythromelalgia. Molecular testing in these patients usually shows presence of either JAK2, CALR, or MPL mutations (90% of cases) or some other clonal marker.

ET is an indolent disorder; however, in advanced cases, ET patients will eventually develop bone marrow fibrosis (leading to cytopenias), or the disease will transform into acute leukemia.

Codes

ICD10CM:
D47.3 – Essential (hemorrhagic) thrombocythemia

SNOMEDCT:
109994006 – Essential thrombocythemia

Look For

Subscription Required

Diagnostic Pearls

Subscription Required

Differential Diagnosis & Pitfalls

Best Tests

Subscription Required

Management Pearls

Subscription Required

Therapy

Subscription Required

References

Subscription Required

Last Reviewed: 04/24/2019
Last Updated: 05/21/2019
Copyright © 2019 VisualDx®. All rights reserved.
Essential thrombocythemia
Print 1 Images
Essential thrombocythemia : Chest pain, Dizziness, Headache, Syncope, Splenomegaly, Transient vision loss, PLT increased
Copyright © 2019 VisualDx®. All rights reserved.